Survivorship support in head and neck cancer: American Head and Neck Society survey
- 10 January 2020
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 42 (5), 939-944
- https://doi.org/10.1002/hed.26066
Abstract
Background The value of supporting cancer survivors beyond formal treatment has become increasingly recognized among clinicians who care for patients with head and neck cancer. Methods A survey was developed by the American Head and Neck Society (AHNS) Survivorship Committee and distributed to members of the AHNS electronically. Results The survey was distributed to 1403 AHNS members, with 202 responses (14.4%). Among survivorship topics, respondents were most likely to address detection of recurrence/second primary malignancies (97.5%), dysphagia (93.1%), and thyroid function (90.1%) with their patients; they were least likely to address sleep disturbance/apnea (27.7%) and body and self‐image issues (29.7%.) Less than half provide patients with a written treatment summary (43.1%) or follow‐up care plan (36.9%). Conclusions These results highlight the need for improved survivorship care planning and offer an opportunity for the development of educational and survivorship research in head and neck cancer care.Keywords
This publication has 20 references indexed in Scilit:
- Suicide: A Major Threat to Head and Neck Cancer SurvivorshipJournal of Clinical Oncology, 2016
- AHNS Series-Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivorsHead & Neck, 2016
- Incidence of Suicide in Patients With Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2015
- Oropharyngeal cancer survivorship in Denmark, 1977–2012Oral Oncology, 2015
- Employment pathways and work‐related issues in head and neck cancer survivorsHead & Neck, 2014
- Survivorship—Competing Mortalities, Morbidities, and Second MalignanciesOtolaryngologic Clinics of North America, 2013
- Prevention of Depression With Escitalopram in Patients Undergoing Treatment for Head and Neck CancerRandomized, Double-blind, Placebo-Controlled Clinical TrialEscitalopram for Depression PreventionJAMA Otolaryngology–Head & Neck Surgery, 2013
- Survivorship Care Plans for Patients With Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2012
- The Value of Periodic Follow-up in the Detection of Recurrences after Radical Treatment in Locally Advanced Head and Neck CancerClinical Oncology, 2010
- Head and neck cancerCancer, 2008